Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.
Health care advocates are supporting legislation to protect access to a federal discount drug program considered critical to community health centers and programs that serve rural and underserved ...